Wide Ranks

CMND

Clearmind Medicine Inc.

1.28

Top Statistics
Market Cap 5 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 1.71 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.4140 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 7 M Total Cash Per Share 1.89 Total Debt 60898
Total Debt To Equity 1.75 Current Ratio 1.71 Book Value Per Share 0.8730
All Measures
Short Ratio 49.00 % Message Board Id finmb_546305599 Shares Short Prior Month 217363
Return On Equity -2.68 City Vancouver Uuid 046b2e4e-b087-3aac-abec-b652bcce32ae
Previous Close 1.33 First Trade Date Epoch Utc 1 B Book Value 0.8730
Beta -1.51 Total Debt 60898 Volume 61175
Price To Book 1.47 Last Split Date 1 B Fifty Two Week Low 0.9210
Total Cash Per Share 1.89 Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Net Income To Common -8439733 Short Percent Of Float 0.0461
Implied Shares Outstanding 4 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 85870 Average Volume10days 85870 Total Cash 7 M
Next Fiscal Year End 1 B Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.33 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.37 Open 1.35
Free Cashflow 162861 State BC Dividend Yield 0.00 %
Return On Assets -0.5795 Time Zone Short Name EST Trailing Eps -1.23
Day Low 1.27 Address1 1220 West 6th Avenue Shares Outstanding 4 M
Price Hint 4 Target High Price 0.0000 Website https://www.clearmindmedicine.com
52 Week Change -0.6343 Average Volume 260504 Recommendation Key none
Forward Eps 0.0000 Compensation As Of Epoch Date 1 B Quick Ratio 168.40 %
Last Split Factor 1:30 Regular Market Day High 1.35 Is_sp_500 False
Profit Margins 0.00 % Debt To Equity 1.75 Fifty Two Week High 6.80
Day High 1.35 Shares Short 187570 Regular Market Open 1.35
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0461 Operating Cashflow -4534682 Currency USD
Time Zone Full Name America/New_York Market Cap 5 M Is_nasdaq_100 False
Zip V6H 1A5 Quote Type EQUITY Industry Biotechnology
Long Name Clearmind Medicine Inc. Regular Market Day Low 1.27 Held Percent Institutions 0.1732
Current Price 1.28 Address2 Suite 101 Enterprise To Ebitda 0.4140
Financial Currency USD Current Ratio 1.71 Industry Disp Biotechnology
Country Canada Float Shares 3 M Two Hundred Day Average 1.35
Enterprise Value -2426641 Forward PE 0.0000 Regular Market Volume 61175
Ebitda -5856612 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally.

It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.

The company also develops MEAI compound which is in IND-enabling study for the treatment of alcohol use disorder; and is in pre-clinical study for treatment of obesity, weight loss, metabolic disorder, and addiction.

In addition, it has a collaboration with SciSparc Ltd.

to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; and with Yissum Research Development Company of the Hebrew University of Jerusalem for the discovery and development of novel psychedelic-derived therapeutics to treat mental disorders.

The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021.

Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.